Hematopoietic Stem Cell Development: An Epigenetic Journey

被引:67
|
作者
Cullen, Sean M. [1 ,2 ]
Mayle, Allison [1 ,3 ]
Rossi, Lara [4 ]
Goodell, Margaret A. [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[4] Univ Bologna, Inst Hematol L&A Seragnoli, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy
来源
关键词
ACUTE MYELOID-LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; DNA METHYLATION; SELF-RENEWAL; ASXL1; MUTATIONS; MYELODYSPLASTIC SYNDROME; DNMT3A MUTATIONS; MOUSE EMBRYO; LINEAGE SPECIFICATION; METHYLTRANSFERASE;
D O I
10.1016/B978-0-12-416022-4.00002-0
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hematopoietic development and homeostasis are based on hematopoietic stem cells (HSCs), a pool of ancestor cells characterized by the unique combination of self-renewal and multilineage potential. These two opposing forces are finely orchestrated by several regulatory mechanisms, comprising both extrinsic and intrinsic factors. Over the past decades, several studies have contributed to dissect the key role of niche factors, signaling transduction pathways, and transcription factors in HSC development and maintenance. Accumulating evidence, however, suggests that a higher level of intrinsic regulation exists; epigenetic marks, by controlling chromatin accessibility, directly shape HSC developmental cascades, including their emergence during embryonic development, maintenance of self-renewal, lineage commitment, and aging. In addition, aberrani epigenetic marks have been found in several hematological malignancies, fond sistent with clinical findings that mutations targeting epigenetic regulators promote leukemogenesis. In this review, we will focus on both normal and malignant hematopoiesis, covering recent findings that illuminate the epigenetic life of HSCs.
引用
收藏
页码:39 / 75
页数:37
相关论文
共 50 条
  • [1] Epigenetic regulation of hematopoietic stem cell development
    Li, C.
    Evans, T.
    Goll, M. G.
    [J]. ZEBRAFISH: GENETICS, GENOMICS, AND TRANSCRIPTOMICS, 4TH EDITION, 2016, 135 : 431 - 448
  • [2] EPIGENETIC CONTROL OF HEMATOPOIETIC STEM CELL DEVELOPMENT
    Liu, Feng
    Wang, Lu
    Ma, Dongyuan
    [J]. EXPERIMENTAL HEMATOLOGY, 2018, 64 : S30 - S30
  • [3] Epigenetic control of Hematopoietic Stem Cell development
    Gore, Aniket, V
    Pham Van
    Butler, Matthew
    Castranova, Daniel
    Weinstein, Brant M.
    [J]. ANGIOGENESIS, 2013, 16 (01) : 245 - 245
  • [4] Understanding the Journey of Human Hematopoietic Stem Cell Development
    Kumar, Akhilesh
    D'Souza, Saritha S.
    Thakur, Abir S.
    [J]. STEM CELLS INTERNATIONAL, 2019, 2019
  • [5] Epigenetic control of dendritic cell development from hematopoietic stem cells
    Kumar, S.
    Hong, J. H.
    Jeong, Y.
    Lee, E.
    Gautam, N.
    Bae, Y. S.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 188 - 188
  • [6] Epigenetic and Epitranscriptomic Factors Make a Mark on Hematopoietic Stem Cell Development
    Kasper D.M.
    Nicoli S.
    [J]. Current Stem Cell Reports, 2018, 4 (1) : 22 - 32
  • [7] Epigenetic regulation of hematopoietic stem cell aging
    Beerman, Isabel
    Rossi, Derrick J.
    [J]. EXPERIMENTAL CELL RESEARCH, 2014, 329 (02) : 192 - 199
  • [8] The epigenetic basis of hematopoietic stem cell aging
    Kramer, Ashley
    Challen, Grant A.
    [J]. SEMINARS IN HEMATOLOGY, 2017, 54 (01) : 19 - 24
  • [9] Epigenetic regulation of hematopoietic stem cell homeostasis
    Jiang, Penglei
    Wang, Hui
    Zheng, Jiachen
    Han, Yingli
    Huang, He
    Qian, Pengxu
    [J]. BLOOD SCIENCE, 2019, 1 (01): : 19 - 28
  • [10] Transcriptional activators, repressors, and epigenetic modifiers controlling hematopoietic stem cell development
    Teitell, MA
    Mikkola, HKA
    [J]. PEDIATRIC RESEARCH, 2006, 59 (04) : 33R - 39R